Web1. jan 2024 · Phesgo 600 mg/600 mg/20,000 units (providing 600 mg pertuzumab, 600 mg trastuzumab and 20,000 units hyaluronidase per 10 mL) single-dose vials: 50242-0260-xx VII. References 1. Phesgo [package insert]. South San Francisco, CA; Genentech, Inc; June 2024. Accessed August 2024. 2. WebPatient Quick Hit - phesgo
PHESGO Prescribing Information - Genentech
WebNázov produktu podľa ŠÚKL. Phesgo 1 200 mg/600 mg injekčný roztok sol inj 1x15 ml/1200 mg/600 mg (liek.inj.skl.) WebPertuzumab/trastuzumab (Phesgo®) provides a combination injection for subcutaneous use. Pertuzumab has previously been accepted by SMC under the orphan medicine process. This advice applies only in the context of an approved NHSScotland Patient Access Scheme (PAS) arrangement delivering the cost-effectiveness results upon which the decision ... chords romeo and juliet mark knopfler
ANEXO I FICHA TÉCNICA O RESUMEN DE LAS CARACTERÍSTICAS …
Web13. okt 2024 · Phesgo contains two active substances, pertuzumab and trastuzumab, which are already authorised for treating early and metastatic HER2-positive breast cancer and … Web11. máj 2024 · Phesgo® is een injectie van 2 al langer bestaande geneesmiddelen die tot nu toe voornamelijk intraveneus (in de aders) worden toegepast voor de behandeling van borstkanker. Vanwege de te verwachte hoge kosten heeft de minister het middel voor deze indicatie in de 'sluis voor dure geneesmiddelen' geplaatst. WebPhesgo® contains pertuzumab, trastuzumab, and hyaluronidase-zzxf. It is best to read this information with our general information about breast cancer. These treatments belong to … chords row row row your boat